Thus, the interaction of phytotherapeutic agents, such Boswellia [224], ginkgo [225], ginseng [226], ginger [227], and curcumin [228] with P-glycoprotein can also modulate the bioavailability of standard cancer drugs and lead to side effects [30,31]. Here, ABCB1 is linked to cancer.